SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.12M | 15.57M | 18.61M | 21.48M | 21.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.12M | 15.57M | 18.61M | 21.48M | 21.89M |
| Cost of Revenue | 51.79M | 60.92M | 66.95M | 70.98M | 72.61M |
| Gross Profit | -39.67M | -45.35M | -48.34M | -49.51M | -50.72M |
| SG&A Expenses | 20.98M | 22.29M | 24.69M | 26.32M | 27.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.77M | 83.20M | 91.64M | 97.30M | 100.37M |
| Operating Income | -60.65M | -67.63M | -73.03M | -75.82M | -78.49M |
| Income Before Tax | -71.64M | -70.65M | -76.11M | -79.46M | -77.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -71.64 | -70.65 | -76.11 | -79.46 | -77.74 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -71.64M | -70.65M | -76.11M | -79.46M | -77.74M |
| EBIT | -60.65M | -67.63M | -73.03M | -75.82M | -78.49M |
| EBITDA | -58.95M | -66.28M | -71.58M | -74.32M | -77.38M |
| EPS Basic | -2.43 | -2.40 | -2.62 | -2.76 | -2.73 |
| Normalized Basic EPS | -1.25 | -1.40 | -1.53 | -1.62 | -1.70 |
| EPS Diluted | -2.43 | -2.40 | -2.62 | -2.76 | -2.73 |
| Normalized Diluted EPS | -1.25 | -1.40 | -1.53 | -1.62 | -1.70 |
| Average Basic Shares Outstanding | 117.92M | 117.71M | 116.59M | 115.24M | 113.85M |
| Average Diluted Shares Outstanding | 117.92M | 117.71M | 116.59M | 115.24M | 113.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |